Zoryve is a cream or foam you put on your skin to treat psoriasis, eczema and seborrheic dermatitis. It works by calming the overactive immune signals that make skin red, scaly and itchy. It is not a steroid, and it can be used in skin folds.
Every report comes from a Lived member, sent anonymously.
Have you tried Zoryve (Roflumilast) for Psoriasis?
Roflumilast, sold as Zoryve, is a prescription cream and foam for inflammatory skin conditions. It is not a corticosteroid (steroid cream). It works through a different route, giving dermatologists a non-steroid option, and the psoriasis cream is approved for use in skin folds such as the groin, armpits and under the breasts. Each product is approved for a specific condition and age group. Zoryve cream 0.3% treats plaque psoriasis, including in skin folds, in adults and children 2 and older. Zoryve cream 0.15% treats mild to moderate atopic dermatitis (eczema) in adults and children 6 and older, and a weaker 0.05% cream treats it in children 2 to 5. Zoryve foam 0.3% treats seborrheic dermatitis, the flaky, red, greasy rash of the scalp, face and chest, in people 9 and older, and plaque psoriasis of the scalp and body in people 12 and older. Because the strengths and forms are matched to different conditions and ages, one should not be swapped for another without the prescriber. Roflumilast is also made as an oral tablet for severe chronic obstructive pulmonary disease (COPD). That is a different product with different dosing and side effects, and this page covers only the skin forms.
Psoriasis, eczema and seborrheic dermatitis all involve immune signaling in the skin that keeps inflammation going, which shows up as redness, scaling, thickening and itch. Inside skin and immune cells, an enzyme called phosphodiesterase 4 (PDE4) breaks down a messenger molecule called cyclic adenosine monophosphate (cyclic AMP), which helps keep inflammatory signaling in check. Roflumilast blocks PDE4, so cyclic AMP builds up inside these cells, and the inflammatory activity driving the rash is turned down. The label notes that exactly how this change produces the improvement in skin is not fully understood. Some of the medicine applied to the skin is absorbed into the bloodstream, which helps explain why a few people notice effects beyond the skin, such as an upset stomach or headache.
Zoryve is applied once a day to the affected areas and rubbed in completely. Wash your hands afterward. It is for skin use only and should not be put in the eyes, mouth or vagina. The foam can be used on the scalp as well as the body. Shake the can before each use and apply a thin layer to skin or scalp that is dry, not wet. The foam's propellant is flammable, so avoid fire, flame and smoking while applying it and right afterward. Use the specific strength and form prescribed for your condition and age.
In clinical trials, side effects were uncommon and few people stopped treatment because of them. The more common effects were diarrhea, nausea and headache, along with trouble sleeping in people treated for psoriasis and vomiting in some people treated for eczema. Some people feel stinging or pain where it is applied. Colds and other upper respiratory infections were reported slightly more often than with the inactive cream. These effects are usually mild. If diarrhea, nausea, sleep problems or skin pain at the application site persist or interfere with daily life, let the prescriber know, since the plan can be adjusted.
Zoryve is not used by people with moderate or severe liver disease, because the liver clears roflumilast and impaired liver function raises the amount in the body. Mild liver impairment does not require a change. The liver breaks down roflumilast using enzymes that some other medicines block, which can raise roflumilast levels and make side effects more likely. Examples studied with oral roflumilast include the antibiotic erythromycin, the antifungal ketoconazole, the antidepressant fluvoxamine and the acid reducer cimetidine. Birth control pills containing gestodene and ethinyl estradiol can have the same effect. The prescriber can weigh whether this matters for you, so share your full medication list. There is not enough information on use in human pregnancy to know the risk, and in animal studies oral roflumilast disrupted labor, so the label advises avoiding it during labor and delivery. During breastfeeding, use it on the smallest area for the shortest time, do not apply it to the nipple or areola, and avoid letting a baby's skin touch treated skin on the chest.
Improvement builds over several weeks. In the trials that led to approval, about 4 in 10 people with plaque psoriasis using the 0.3% cream had clear or almost clear skin after 8 weeks, compared with fewer than 1 in 10 using the cream base alone. In eczema, about 3 in 10 reached clear or almost clear skin after 4 weeks, roughly twice the rate with the base cream. In seborrheic dermatitis, most people using the foam reached clear or almost clear skin by 8 weeks, though many also improved with the inactive foam alone. Itch often improved too. Results vary, and many people see partial rather than complete clearing. These are chronic conditions, so the rash may return after stopping. Trials followed people using the cream or foam for up to about a year with no new safety concerns, and the dermatologist will check how well it is working and whether it should be continued, combined with other treatments or changed.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Zoryve (Roflumilast), what you've noticed, or ask the community a question.